FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2162007922> ?p ?o ?g. }

• W2162007922 endingPage "315" @default.
• W2162007922 startingPage "309" @default.
• W2162007922 abstract "Background & AimsIntravenous administration of albumin decreases the incidence of renal failure and mortality among patients with spontaneous bacterial peritonitis (SBP). However, it is unclear whether it should be given to all patients with SBP; we evaluated its efficacy.MethodsWe analyzed data from all episodes of SBP (n = 216) during a 7-year period that occurred in a nonselected series of 167 patients with cirrhosis. Low-risk episodes (urea <11 mmol/L and bilirubin <68 μmol/L) were not treated with albumin, whereas high-risk episodes (urea >11 mmol/L and/or bilirubin >68 μmol/L) were or were not given albumin at the discretion of the attending physician.ResultsSixty-four episodes of SBP (29.6%) were low risk and not treated with albumin, whereas 152 (70.4%) were high risk; 73 of these (48%) were treated with albumin and 79 (52%) were not. Renal failure before SBP resolution was less frequent after low-risk episodes than high-risk episodes (4.7% versus 25.6%; P = .001), in-hospital mortality was lower (3.1% versus 38.2%; P < .001), and the 3-month probability of survival was higher (93% versus 53%; P < .001). In an analysis of only the high-risk group, patients who received albumin had lower in-hospital mortality than those not treated with albumin (28.8% versus 46.8%; P = .02) and a greater 3-month probability of survival (62% versus 45%; P = .01).ConclusionsAlbumin therapy increases survival of patients who have high-risk episodes of SBP, although it does not seem to be necessary for patients with low risk of death. Intravenous administration of albumin decreases the incidence of renal failure and mortality among patients with spontaneous bacterial peritonitis (SBP). However, it is unclear whether it should be given to all patients with SBP; we evaluated its efficacy. We analyzed data from all episodes of SBP (n = 216) during a 7-year period that occurred in a nonselected series of 167 patients with cirrhosis. Low-risk episodes (urea <11 mmol/L and bilirubin <68 μmol/L) were not treated with albumin, whereas high-risk episodes (urea >11 mmol/L and/or bilirubin >68 μmol/L) were or were not given albumin at the discretion of the attending physician. Sixty-four episodes of SBP (29.6%) were low risk and not treated with albumin, whereas 152 (70.4%) were high risk; 73 of these (48%) were treated with albumin and 79 (52%) were not. Renal failure before SBP resolution was less frequent after low-risk episodes than high-risk episodes (4.7% versus 25.6%; P = .001), in-hospital mortality was lower (3.1% versus 38.2%; P < .001), and the 3-month probability of survival was higher (93% versus 53%; P < .001). In an analysis of only the high-risk group, patients who received albumin had lower in-hospital mortality than those not treated with albumin (28.8% versus 46.8%; P = .02) and a greater 3-month probability of survival (62% versus 45%; P = .01). Albumin therapy increases survival of patients who have high-risk episodes of SBP, although it does not seem to be necessary for patients with low risk of death." @default.
• W2162007922 created "2016-06-24" @default.
• W2162007922 creator A5013506631 @default.
• W2162007922 creator A5014239140 @default.
• W2162007922 creator A5034682808 @default.
• W2162007922 creator A5045641131 @default.
• W2162007922 creator A5046565205 @default.
• W2162007922 creator A5051374525 @default.
• W2162007922 creator A5056488625 @default.
• W2162007922 creator A5076926398 @default.
• W2162007922 creator A5077891286 @default.
• W2162007922 creator A5089220165 @default.
• W2162007922 creator A5089593649 @default.
• W2162007922 date "2012-03-01" @default.
• W2162007922 modified "2023-10-17" @default.
• W2162007922 title "Role of Albumin Treatment in Patients With Spontaneous Bacterial Peritonitis" @default.
• W2162007922 cites W1548753216 @default.
• W2162007922 cites W1608294118 @default.
• W2162007922 cites W1975152603 @default.
• W2162007922 cites W1997948095 @default.
• W2162007922 cites W2005568070 @default.
• W2162007922 cites W2008725020 @default.
• W2162007922 cites W2012746560 @default.
• W2162007922 cites W2029771605 @default.
• W2162007922 cites W2036163947 @default.
• W2162007922 cites W2048059462 @default.
• W2162007922 cites W2054766712 @default.
• W2162007922 cites W2064182480 @default.
• W2162007922 cites W2064914299 @default.
• W2162007922 cites W2073012155 @default.
• W2162007922 cites W2075729861 @default.
• W2162007922 cites W2109695435 @default.
• W2162007922 cites W2120044421 @default.
• W2162007922 cites W2121243356 @default.
• W2162007922 cites W2131206408 @default.
• W2162007922 cites W2149108783 @default.
• W2162007922 cites W2149266696 @default.
• W2162007922 cites W2151039065 @default.
• W2162007922 cites W2152418238 @default.
• W2162007922 cites W2153155205 @default.
• W2162007922 cites W2157556100 @default.
• W2162007922 cites W2161125351 @default.
• W2162007922 cites W2165252059 @default.
• W2162007922 cites W2169814055 @default.
• W2162007922 cites W2322673970 @default.
• W2162007922 cites W2599527603 @default.
• W2162007922 doi "https://doi.org/10.1016/j.cgh.2011.11.012" @default.
• W2162007922 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/22094025" @default.
• W2162007922 hasPublicationYear "2012" @default.
• W2162007922 type Work @default.
• W2162007922 sameAs 2162007922 @default.
• W2162007922 citedByCount "60" @default.
• W2162007922 countsByYear W21620079222012 @default.
• W2162007922 countsByYear W21620079222013 @default.
• W2162007922 countsByYear W21620079222014 @default.
• W2162007922 countsByYear W21620079222015 @default.
• W2162007922 countsByYear W21620079222016 @default.
• W2162007922 countsByYear W21620079222017 @default.
• W2162007922 countsByYear W21620079222018 @default.
• W2162007922 countsByYear W21620079222019 @default.
• W2162007922 countsByYear W21620079222020 @default.
• W2162007922 countsByYear W21620079222021 @default.
• W2162007922 countsByYear W21620079222022 @default.
• W2162007922 countsByYear W21620079222023 @default.
• W2162007922 crossrefType "journal-article" @default.
• W2162007922 hasAuthorship W2162007922A5013506631 @default.
• W2162007922 hasAuthorship W2162007922A5014239140 @default.
• W2162007922 hasAuthorship W2162007922A5034682808 @default.
• W2162007922 hasAuthorship W2162007922A5045641131 @default.
• W2162007922 hasAuthorship W2162007922A5046565205 @default.
• W2162007922 hasAuthorship W2162007922A5051374525 @default.
• W2162007922 hasAuthorship W2162007922A5056488625 @default.
• W2162007922 hasAuthorship W2162007922A5076926398 @default.
• W2162007922 hasAuthorship W2162007922A5077891286 @default.
• W2162007922 hasAuthorship W2162007922A5089220165 @default.
• W2162007922 hasAuthorship W2162007922A5089593649 @default.
• W2162007922 hasConcept C120665830 @default.
• W2162007922 hasConcept C121332964 @default.
• W2162007922 hasConcept C126322002 @default.
• W2162007922 hasConcept C141071460 @default.
• W2162007922 hasConcept C165616093 @default.
• W2162007922 hasConcept C2776125364 @default.
• W2162007922 hasConcept C2777214474 @default.
• W2162007922 hasConcept C2777364826 @default.
• W2162007922 hasConcept C2777513400 @default.
• W2162007922 hasConcept C61511704 @default.
• W2162007922 hasConcept C71924100 @default.
• W2162007922 hasConcept C90924648 @default.
• W2162007922 hasConceptScore W2162007922C120665830 @default.
• W2162007922 hasConceptScore W2162007922C121332964 @default.
• W2162007922 hasConceptScore W2162007922C126322002 @default.
• W2162007922 hasConceptScore W2162007922C141071460 @default.
• W2162007922 hasConceptScore W2162007922C165616093 @default.
• W2162007922 hasConceptScore W2162007922C2776125364 @default.
• W2162007922 hasConceptScore W2162007922C2777214474 @default.
• W2162007922 hasConceptScore W2162007922C2777364826 @default.
• W2162007922 hasConceptScore W2162007922C2777513400 @default.
• W2162007922 hasConceptScore W2162007922C61511704 @default.

• next